Systemic Lupus Erythematosus — The Lupus prEGnAnCY Cohort: An International Prospective Cohort of Lupus Pregnancies
Citation(s)
Al Arfaj AS, Khalil N Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia. Lupus. 2010 Dec;19(14):1665-73. doi: 10.1177/0961203310378669. Epub 2010 Oct 14.
Clowse ME, Jamison M, Myers E, James AH A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008 Aug;199(2):127.e1-6. doi: 10.1016/j.ajog.2008.03.012. Epub 2008 May 5.
Joseph KS The fetuses-at-risk approach: clarification of semantic and conceptual misapprehension. BMC Pregnancy Childbirth. 2008 Mar 26;8:11. doi: 10.1186/1471-2393-8-11. Review.
Liu J, Zhao Y, Song Y, Zhang W, Bian X, Yang J, Liu D, Zeng X, Zhang F Pregnancy in women with systemic lupus erythematosus: a retrospective study of 111 pregnancies in Chinese women. J Matern Fetal Neonatal Med. 2012 Mar;25(3):261-6. doi: 10.3109/14767058.2011.572310. Epub 2011 Apr 19.
Petri M, Allbritton J Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort. J Rheumatol. 1993 Apr;20(4):650-6.
Shand AW, Algert CS, March L, Roberts CL Second pregnancy outcomes for women with systemic lupus erythematosus. Ann Rheum Dis. 2013 Apr;72(4):547-51. doi: 10.1136/annrheumdis-2011-201210. Epub 2012 Jun 29.
Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010 Nov;5(11):2060-8. doi: 10.2215/CJN.00240110. Epub 2010 Aug 5. Review.
The Lupus prEGnAnCY Cohort: An International Prospective Cohort of Lupus Pregnancies
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
